Gastro Medical News about Infliximab

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Impact of Concomitant Immunomodulator Use on Long-Term Outcomes in Patients Receiving Scheduled Maintenance Infliximab
Digestive Diseases and Sciences, 06/22/09

Moss AC et al. - The combination of maintenance infliximab and an immunomodulator produced modest improvements in outcomes beyond maintenance infliximab alone in this cohort.

Exclusive Author Commentary
Alan C. Moss, 06/22/09

Our study found that combining azathioprine or 6MP with infliximab (combination therapy) produced differences in remission rates that were significant at 1 year, but not 2 or 5 year end-points. Theses results are similar to post-hoc analyses of the maintenance studies of infliximab, adalimumab and certolizumab; patients on combination therapy had similar remission rates to those on monotherapy with an anti-TNF. These populations, and ours, are different to those enrolled in the recent SONIC study. The patients enrolled in SONIC had a shorter duration of disease, and were all immunomodulator-naive. Thus one can speculate that intervention with combination therapy early in the course of Crohn's disease produces better results than using this approach later on. Whether using combination therapy in this population will result in any higher risk for serious infections or lymphoma is currently unknown.

<< Previous
Precut Papillotomy: A Risky Technique Not Only for Experts but...

Next >>
Fetal Growth Restriction Is Associated With Prioritization of...